0.39%
8.45%
18.19%
27.20%
17.46%
148.71%
150.46%
AI Spotlight on CAH
Company Description
Cardinal Health, Inc.operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
The company operates in two segments, Pharmaceutical and Medical.The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals.
The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Market Data
| Last Price | 128.26 |
| Change Percentage | 0.39% |
| Open | 127.16 |
| Previous Close | 127.76 |
| Market Cap ( Millions) | 31040 |
| Volume | 3837096 |
| Year High | 132.84 |
| Year Low | 93.17 |
| M A 50 | 121.72 |
| M A 200 | 109.21 |
Financial Ratios
| FCF Yield | -1.65% |
| Dividend Yield | 1.57% |
| ROE | -41.11% |
| Debt / Equity | -254.30% |
| Net Debt / EBIDTA | 155.07% |
| Price To Book | -10.38 |
| Price Earnings Ratio | 23.69 |
| Price To FCF | -60.51 |
| Price To sales | 0.14 |
| EV / EBITDA | 14.23 |
News
- Jan -30 - Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
- Jan -30 - CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
- Jan -30 - Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- Jan -30 - Cardinal Health (CAH) Surpasses Q2 Earnings and Revenue Estimates
- Jan -30 - Cardinal Health lifts 2025 profit forecast on specialty drugs demand
- Jan -30 - Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
- Jan -28 - Buy These 5 Stocks Set to Win Big After Earnings Results This Week
- Jan -27 - Cardinal Health to Report Q2 Earnings: What's in Store for the Stock?
- Jan -23 - Cardinal Health (CAH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Jan -22 - Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
- Jan -16 - Cardinal Health Stock May Gain With New Texas Distribution Center
- Jan -16 - Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
- Jan -14 - Cardinal Health, Inc. (CAH) CEO Jason Hollar presents at J.P. Morgan Healthcare Conference (Transcript)
- Jan -14 - Consumer Sentiment Declines Amid Rate Cut Uncertainty: 4 Safe Bets
- Jan -14 - Cardinal Health to open new distribution center in Fort Worth, Texas
- Jan -14 - Cardinal Health forecasts annual profit at higher end of prior range
- Jan -10 - Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
- Jan -10 - Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
- Jan -10 - Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know
- Jan -07 - Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Pharmaceutical
Expected Growth : 5.5 %
What the company do ?
Cardinal Health, Inc.'s Pharmaceutical segment distributes branded and generic pharmaceuticals, over-the-counter healthcare products, and consumer goods to retail pharmacies and other healthcare providers.
Why we expect these perspectives ?
Cardinal Health's Pharmaceutical segment growth of 5.5% is driven by increasing demand for generic drugs, expansion of specialty pharmaceutical services, and strategic acquisitions. Additionally, the company's focus on operational efficiency and cost savings initiatives have contributed to the growth. Furthermore, the rise in healthcare expenditure and an aging population have also fueled the segment's growth.
Segment n°2 -> Medical
Expected Growth : 5.8 %
What the company do ?
Medical from Cardinal Health, Inc. provides medical products and pharmaceuticals to healthcare providers, serving as a vital link between manufacturers and healthcare facilities.
Why we expect these perspectives ?
Cardinal Health's Medical segment growth of 5.8% is driven by increasing demand for medical products and supplies, particularly in the areas of surgical and infection prevention. Additionally, the company's strategic acquisitions and partnerships have expanded its product offerings and geographic reach, contributing to growth. Furthermore, the ongoing shift towards outpatient care and the need for cost-effective solutions are also driving demand for Cardinal Health's medical products.
Segment n°3 -> Corporate
Expected Growth : 6.2 %
What the company do ?
Cardinal Health, Inc. is a Fortune 500 healthcare services company that provides medical products and pharmaceuticals to hospitals, clinics, and pharmacies.
Why we expect these perspectives ?
Cardinal Health, Inc.'s 6.2% corporate growth is driven by strategic acquisitions, expansion into emerging markets, and increased demand for medical products and services. Additionally, the company's focus on operational efficiency, cost savings initiatives, and investments in digital transformation have contributed to its growth momentum.
Cardinal Health, Inc. Products
| Product Range | What is it ? |
|---|---|
| Pharmaceutical Distribution | Cardinal Health's pharmaceutical distribution segment provides pharmaceuticals, vaccines, and consumer goods to retail pharmacies, hospitals, and clinics. |
| Medical Products | Cardinal Health's medical products segment offers a range of medical products, including surgical and procedural products, infection prevention products, and orthopedic and wound care products. |
| Cardinal Health at-Home Solutions | Cardinal Health's at-home solutions segment provides medical products and services to patients in their homes, including respiratory therapy, sleep therapy, and medical equipment. |
| Nuclear and Precision Health | Cardinal Health's nuclear and precision health segment provides radiopharmaceuticals and molecular imaging agents for diagnostic and therapeutic applications. |
| Patient Recovery | Cardinal Health's patient recovery segment offers a range of products and services to support patient recovery, including pain management, wound care, and orthopedic products. |
Cardinal Health, Inc.'s Porter Forces
Threat Of Substitutes
Cardinal Health, Inc. operates in a highly competitive industry, but the threat of substitutes is mitigated by the company's diversified product portfolio and strong relationships with its customers.
Bargaining Power Of Customers
Cardinal Health, Inc. has a large and diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products and services are often critical to its customers' operations, making it difficult for customers to negotiate prices or switch to alternative suppliers.
Bargaining Power Of Suppliers
Cardinal Health, Inc. relies on a large network of suppliers to provide raw materials and components for its products. While the company has some bargaining power due to its size and scale, suppliers may still have some negotiating power, particularly if they are sole-source providers of critical components.
Threat Of New Entrants
The medical products and pharmaceutical distribution industries are highly regulated and require significant capital investments, making it difficult for new entrants to enter the market. Additionally, Cardinal Health, Inc.'s established relationships with customers and suppliers create barriers to entry for new competitors.
Intensity Of Rivalry
The medical products and pharmaceutical distribution industries are highly competitive, with several large players competing for market share. Cardinal Health, Inc. faces intense competition from rivals such as McKesson Corporation, AmerisourceBergen Corporation, and Owens & Minor, Inc.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 254.11% |
| Debt Cost | 4.82% |
| Equity Weight | -154.11% |
| Equity Cost | 7.52% |
| WACC | 0.65% |
| Leverage | -164.89% |
Cardinal Health, Inc. : Quality Control
Cardinal Health, Inc. passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| COR | Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and … |
| REGN | Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular … |
| ABBV | AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat … |
| JNJ | Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under … |
| MCK | McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
AbbVie
A-Score
1-Year Total Return ->
🥈
Cencor
A-Score
1-Year Total Return ->
🥉
Cardinal Health
A-Score
1-Year Total Return ->
4
J&J
A-Score
1-Year Total Return ->
5
McKesson
A-Score
1-Year Total Return ->
6
